A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples